Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
64 Cards in this Set
- Front
- Back
Most common mechanism of action of antiviral drugs
|
Inhibiting viral nucleic acid synthesis
|
|
How antiviral nucleoside analogues function
|
Incorporation of analogue terminates viral DNA or RNA replication, most current analogues have modifications to the ribose part of the molecule
|
|
Description of prototypical anti-herpes drug
|
Acyclovir- guanosine analog with an acyclic group replacing the ribose
|
|
Mechanism of viral resistance to acyclovir
|
Viral enzymes mutate and no longer add initial phosphate to the drug
|
|
Alternative therapeutic options to acyclovir
|
Foscarnet or Cidofovir
|
|
Pregnancy and Acyclovir
|
Acyclovir NOT approved for pregnancy but no birth defects have been associated with its use in pregnant women, effective in near-term women with recurrent genital herpes to prevent spread of virus to newborn
|
|
Viruses targeted by Foscarnet or Cidofovir
|
HSV or VZV (varicella zoster virus)
|
|
Drug of choice for CMV infection
|
Ganciclovir (for CMV that is life and sight-threatening), can be used prophylactically in transplant patients
|
|
Serious Ganciclovir side effects
|
Aspermatogenesis, granulocytopenia, thrombocytopenia, animal models show carcinogenesis and teratogenesis, retinal detachment in patients with CMV retinitis
|
|
Association of resistance in Ganciclovir
|
Reistance is associated with persistent infection
|
|
Alternative drugs used with Ganciclovir-resistant CMV infection
|
Foscarnet or Cidofovir
|
|
Drug that has replaced Ganciclovir in certain cases
|
Valganciclovir replaces IV and oral ganciclovir for patients with CMV retinitis that is not life or sight threatening
|
|
In patients with AIDS, drug used to treat CMV
|
Cidofovir administered IV to delay progression of CMV retinitis in AIDS patients
|
|
Contraindication of IV Cidofovir
|
Contraindicated in patients taking other nephrotoxic agents
|
|
Infections targeted by Cidofovir
|
Acyclovir-resistent HSV or VZV (varicella zoster virus)
|
|
What clinical diseases are caused by Varicella Zoster Virus (VZV)
|
Causative agent of chicken pox or shingles
|
|
Vaccine against Varicella Zoster Virus (VZV)
|
Varivax- live attenuated virus vaccine against chicken pox
|
|
Varicella Zoster Virus vaccine for older patients
|
Zostavax used in patients >60 yrs old (immunocompetent)
|
|
Contraindications for Zostavax (VZV vaccine)
|
Contraindicated for immunocompromised patients and people with a history of anaphylactic shock to gelatin, neomycin, or other components of vaccine
|
|
Clinical use of Zostavax
|
Used to prevent shingles in people >60 yrs old (immunocompetent)
|
|
Enzyme encoded by HIV
|
Reverse Transcriptase
|
|
Effectiveness of HIV therapy measured by...
|
Viral RNA load, CD4+ T cell counts
|
|
Mechanism of action of Nucleoside Transcriptase Inhibitors (NRTI)
|
Inhibit Reverse Transcriptase--> block transcription of viral RNA genome into DNA
|
|
Adverse side effects of Nucleoside Reverse Transcriptase Inhibitors (NRTI)
|
Potentiall fatal lactic acidosis, peripheral lipoatrophy, central fat accumulation, hyperlipidemia
|
|
Nucleoside Reverse Transcriptase Inhibitor drugs that are most often seen to have adverse side effects
|
Stavudine and Zidovudine
|
|
Drug (NRTI) most often associated with lactic acidosis
|
Stavudine
|
|
Protease inhibitor site of action
|
Synthesis of viral proteins
|
|
Metabolism of HIV protease inhibitors
|
HIV protease inhibitors metabolized by and are inhibitors of CYP3A4, can interfere with metabolism of other drugs
|
|
Good HIV Protease Inhibitor for Pediatric Patients
|
Indinavir
|
|
Treatment of choice for naive HIV patients
|
Lopinavir + Ritonavir
|
|
Drugs good for HIV patients that have had extensive treatment and drug resistance problems
|
Tipranavir + low dose Ritonavir
|
|
Classification of other inhibitors of HIV reverse transcriptase
|
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
|
|
Drugs classified as Non-Nucleoside Reverse Transcriptase Inhibitors
|
Delavirdine, Nevirapine, Efavirenz
|
|
Contraindication of Efavirenz (non-nucleoside RT inhibitor)
|
Efavirenz contraindicated in pregnant women
|
|
Drug that is an HIV Fusion Inhibitor
|
Enfuvirtide prevents HIV from entering host cell by blocking gp41
|
|
Definition of an Integrase Inhibitor
|
Integrase Inhibitor blocks integration of viral DNA into host genome
|
|
Investigational Anti-HIV drug
|
Maraviroc for patients with CCR5-tropic HIV-1
|
|
Treatment of HIV patients (acronym)
|
Highly Active Anti-Retroviral Therapy (HAART), combination therapy
|
|
Initial combination therapy for HIV patients
|
2 NRTIs + Efavirenz (NNRTI)
OR 2 NRTIs + PI combination (Lopinavir/Ritonavir) |
|
Combination therapy for HIV patients with advanced disease
|
Darunavir or Tipranavir + Enfuvirtide
|
|
Prevention of perinatal HIV transmission
|
If not on therapy at onset of pregnancy, should wait until 10-12 weeks of gestation to begin
AZT- administer to newborn for 6 weeks |
|
Prevention of perinatal HIV- drugs contraindicated in pregnant women
|
Stavudine and Didanosine
Enfavirenz |
|
Anti-Influenza Drugs
|
Oseltamivir, Zanamivir treat Influenza A and B
|
|
Mechanism of action of Oseltamivir and Zanamivir (Anti-Influenza drugs)
|
Block neuraminidase activity required for release of new virus particles from infected cells
|
|
Anti-influenza drug for patients 1 yr and older, route of administration
|
Oseltamivir (oral)
|
|
Anti-influenza drug for patients 7 yrs and older, route of administration
|
Zanamivir (inhaled)
|
|
Most effective method of preventing influenza infection
|
Annual immunization against Influenza A and B most effective method of preventing infection
|
|
2 types of influenze vaccine formulations, route of administration
|
Type 1- inactivated, administered IM
Type 2- live-attenuated, intranasal |
|
Patient population targeted for use of Type 1 Influenza vaccine
|
Use Type 1 Influenza Vaccine for:
Children aged 6-59 months Pregnant women (any trimester) People older than 50 |
|
Patient population contraindicated for use of Type 2 Influenza vaccine
|
Do not use Type 2 Influenza vaccine in pregnant patients, immunosuppressed patients
Patients that receive this vaccine should avoid contact with severely immunocompromised patients for 7 days |
|
Drugs to treat H5N1 (avian flu)
|
Oseltamivir and Zanamivir best options for prophylaxis and early treatment of susceptible H5N1 strains
|
|
Symptoms of H1N1 (swine flu)
|
Vomiting, diarrhea, etc.
|
|
H1N1 is NOT caused by...
|
H1N1 is not caused by eating pork or pork products
|
|
Mechanism of action of Foscarnet
|
Foscarnet blocks viral polymerases (DNA pol, RNA pol, and reverse transcriptase) by binding to pyrophosphate site
|
|
Diseases targeted by Foscarnet
|
Foscarnet can be used to treat herpes, varicella, CMV, hepatitis B, HIV
|
|
Clinical uses associated with Foscarnet
|
Foscarnet can be used to treat acyclovir-resistant HSV in AIDS patients, acyclovir-resistant VZV, CMV retinitis in immunosuppressed patients (alternative to ganciclovir)
|
|
Anti-Hepatitis B and C drugs
|
Drugs that can treat Hepatitis B and C: Lamivudine, Adefovir Dipivoxil, Interferon alpa, Ribavarin
|
|
Mechanism of action of Human Interferons (anti-hepatitis B and C drug)
|
Human interferons are glycoproteins secreted by lymphocytes and macrophages in response to viral infections, interferons promote an antiviral state in uninfected cells
|
|
Clinical use of Ribavarin
|
Ribavarin is used in combination with Interferon alpha for treating chronic hepatitis C virus
|
|
Patient populations for whom Ribavirin is contraindicated (and why)
|
Ribavarin can stay in RBCs for month, should not be given to pregnant women because it is teratogenic and embryotoxic
Pregnant women should avoid contact with people using Ribavarin; women taking Ribavarin should not get pregnant for 6 months |
|
Vaccine to treat Human Papilloma Virus
|
Gardasil
|
|
Patient population for whom Gardasil is contraindicated
|
Gardasil is contraindicated in pregnant women
|
|
Description of Rotavirus disease manifestation
|
Rotavirus causes gastroenteritis with fever, vomiting, diarrhea, dehydration
|
|
Adverse side effect of HIV Protease Inhibitors
|
Fat redistribution (e.g. buffalo hum) occurs with Protease Inhibitors
|